RE: Credit where credit is due26 Nov 2024 12:19
Hi JustHereForHemo,
I hate to say this but your delusional.
You've not looked at the accounts or the cash-burn rate!
So let me try & help you .....
From the half year report
"During the six months ended 30 June 2024, the Group recorded a loss before taxation of £2,815,604 (2023: £4,323,564 loss), including operating costs of £2,369,455 (2023: £3,896,308)"
"The Company had cash and cash equivalents totalling £1,642,762 as of 30 June 2024."
The company raised an additional £600K less cots on 11th November.
Put the 2 sums together & you get to less than £2.25M of cash yet the company spent £2.37M in the 1st half of the year.
So please tell everyone how you believe a fund raise is not urgently needed when they also have to factor in the cost of the EGM etc, re-issue of share certificates etc.
You keep going on about No more Peterhouse Specials. Well if there not going to have any more of them, then surely they would be changing there broker to someone else ?
Because even if they do get investment from institutions Peterhouse will still be able to place some shares with there friends & HEMO will gladly take the cash on offer.
HEMO have backed themselves into a terrible corner, but sadly you just can't see that for the rose coloured glasses your wearing.
You simply failed to understand what the words consolidation do to a share price, as I posted in my 1st post on the HEMO Bb on friday just go & look at the decimation that occurred with SYNT (a FTSE 250 company at the time).
Hopefully things work out for you in the long run (2 -3 years), but its going to sadly get a lot worse before it gets better
LOTM